Maryland Senate Bill 357

---

Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on January 16 2025 - 25% progression
Action: 2025-01-22 - Hearing 2/06 at 1:00 p.m.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Requiring the Prescription Drug Affordability Board, under certain circumstances, to establish a process for setting upper payment limits for all purchases and payor reimbursements of prescription drug products in the State that the Board determines have led or will lead to affordability challenges; authorizing the Board to reconsider an upper payment limit for a drug that becomes a current shortage; altering requirements related to the setting of upper payment limits by the Board; etc.

Prescription Drug Affordability Board - Authority for Upper Payment Limits (Lowering Prescription Drug Costs for All Marylanders Now Act)

Sen. Dawn Gile [D]

Sen. Brian Feldman [D]

Date	Chamber	Action
2025-01-22	Senate	Hearing 2/06 at 1:00 p.m.
2025-01-16	Senate	First Reading Finance

HB424 (Crossfiled) 2025-02-21 - Third Reading Passed (94-38)

Chapter	Article	Section	Citation Type	Statute Text
Health - General	21	2C-01	(n/a)	See Bill Text
Health - General	21	2C-11	(n/a)	See Bill Text
Health - General	21	2C-13	(n/a)	See Bill Text
Health - General	21	2C-14	(n/a)	See Bill Text
Health - General	21	2C-16	(n/a)	See Bill Text

Type	Source
Summary	https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/SB0357?ys=2025RS
Text	https://mgaleg.maryland.gov/2025RS/bills/sb/sb0357f.pdf